B-Characteristic	0	7	Retinal
I-Characteristic	8	13	nerve
I-Characteristic	14	19	fiber
I-Characteristic	20	25	layer
I-Characteristic	26	35	thickness
O	36	38	in
B-Disease	39	47	dominant
I-Disease	48	53	optic
I-Disease	54	61	atrophy
O	62	74	measurements
O	75	77	by
B-Diagnostic_tool	78	85	optical
I-Diagnostic_tool	86	95	coherence
I-Diagnostic_tool	96	106	tomography
O	107	110	and
O	111	122	correlation
O	123	127	with
B-Characteristic	128	131	age
O	131	132	.

O	134	136	To
O	137	144	measure
O	145	148	the
B-Characteristic	149	156	retinal
I-Characteristic	157	162	nerve
I-Characteristic	163	168	fiber
I-Characteristic	169	174	layer
I-Characteristic	175	176	(
I-Characteristic	176	180	RNFL
I-Characteristic	180	181	)
I-Characteristic	182	191	thickness
O	192	194	by
O	195	200	means
O	201	203	of
B-Diagnostic_tool	204	211	optical
I-Diagnostic_tool	212	221	coherence
I-Diagnostic_tool	222	232	tomography
O	233	234	(
B-Diagnostic_tool	234	237	OCT
O	237	238	)
O	239	241	in
O	242	250	patients
O	251	255	with
B-Disease	256	264	dominant
I-Disease	265	270	optic
I-Disease	271	278	atrophy
O	279	280	(
B-Disease	280	283	DOA
O	283	284	)
O	284	285	.

O	286	291	Cross
O	291	292	-
O	292	301	sectional
O	302	307	study
O	307	308	.

O	309	315	Thirty
O	315	316	-
O	316	321	three
O	322	330	patients
O	331	335	from
O	336	338	15
O	339	348	pedigrees
O	349	353	with
B-Disease	354	357	DOA
O	358	367	harboring
B-Characteristic	368	380	heterozygous
I-Characteristic	381	390	mutations
I-Characteristic	391	393	in
I-Characteristic	394	397	the
I-Characteristic	398	402	OPA1
I-Characteristic	403	407	gene
O	408	411	and
O	412	414	43
B-Characteristic	415	422	healthy
I-Characteristic	423	431	subjects
O	432	436	were
O	437	445	enrolled
O	445	446	.

O	447	450	The
B-Anatomy	451	456	RNFLs
O	457	459	of
B-Disease	460	463	DOA
O	464	472	patients
O	473	477	were
O	478	485	studied
O	486	488	by
B-Diagnostic_tool	489	492	OCT
O	493	496	and
O	497	505	compared
O	506	510	with
O	511	516	those
O	517	519	of
O	520	522	43
B-Characteristic	523	530	healthy
I-Characteristic	531	539	subjects
O	540	547	matched
O	548	551	for
B-Characteristic	552	555	age
O	556	559	and
B-Characteristic	560	565	optic
I-Characteristic	566	571	nerve
I-Characteristic	572	576	head
I-Characteristic	577	578	(
I-Characteristic	578	581	ONH
I-Characteristic	581	582	)
I-Characteristic	583	587	size
O	587	588	.

B-Characteristic	589	596	Retinal
I-Characteristic	597	602	nerve
I-Characteristic	603	608	fiber
I-Characteristic	609	614	layer
I-Characteristic	615	624	thickness
O	624	625	.

B-Disease	626	634	Dominant
I-Disease	635	640	optic
I-Disease	641	648	atrophy
O	649	657	patients
O	658	666	revealed
O	667	668	a
B-Symptom	669	680	significant
I-Symptom	681	685	RNFL
I-Symptom	686	695	thickness
I-Symptom	696	705	reduction
I-Symptom	706	708	in
I-Symptom	709	712	all
I-Symptom	713	722	quadrants
O	722	723	,
O	724	728	with
O	729	730	a
O	731	743	preferential
O	744	755	involvement
O	756	758	of
O	759	762	the
B-Anatomy	763	771	temporal
I-Anatomy	772	775	and
I-Anatomy	776	784	inferior
I-Anatomy	785	792	sectors
O	792	793	.

O	794	797	The
B-Symptom	798	809	progressive
I-Symptom	810	817	decline
I-Symptom	818	820	of
I-Symptom	821	825	RNFL
I-Symptom	826	835	thickness
I-Symptom	836	840	with
I-Symptom	841	844	age
O	845	848	was
O	849	856	similar
O	857	859	to
O	860	864	that
O	865	873	observed
O	874	876	in
B-Characteristic	877	884	healthy
I-Characteristic	885	893	subjects
O	894	897	and
O	898	901	was
O	902	906	more
O	907	914	evident
O	915	917	in
O	918	921	the
O	922	923	2
O	924	933	quadrants
O	934	938	with
B-Symptom	939	945	higher
I-Symptom	946	954	residual
I-Symptom	955	962	amounts
I-Symptom	963	965	of
I-Symptom	966	972	fibers
O	972	973	,
O	974	978	that
O	979	981	is
O	981	982	,
O	983	986	the
O	987	995	superior
O	996	999	and
O	1000	1003	the
O	1004	1012	inferior
O	1012	1013	.

O	1014	1017	The
B-Anatomy	1018	1026	temporal
I-Anatomy	1027	1035	quadrant
O	1036	1039	was
O	1040	1050	profoundly
B-Symptom	1051	1059	depleted
I-Symptom	1060	1062	of
I-Symptom	1063	1068	fiber
O	1069	1071	so
O	1072	1076	that
O	1077	1080	the
O	1081	1088	further
O	1089	1093	rate
O	1094	1096	of
B-Symptom	1097	1101	loss
I-Symptom	1102	1104	of
I-Symptom	1105	1112	microns
O	1113	1116	per
O	1117	1121	year
O	1122	1124	is
O	1125	1130	close
O	1131	1133	to
O	1134	1138	zero
O	1138	1139	,
O	1140	1147	whereas
O	1148	1151	the
B-Anatomy	1152	1157	nasal
I-Anatomy	1158	1166	quadrant
O	1167	1170	was
O	1171	1177	spared
O	1178	1181	the
O	1182	1186	most
O	1187	1189	by
B-Symptom	1190	1207	neurodegeneration
O	1207	1208	.

O	1209	1212	The
O	1213	1220	present
O	1221	1229	findings
O	1229	1230	,
O	1231	1236	taken
O	1237	1239	in
O	1240	1251	conjunction
O	1252	1256	with
O	1257	1260	the
O	1261	1268	authors
O	1268	1269	'
O	1270	1278	previous
O	1279	1290	description
O	1291	1293	of
B-Characteristic	1294	1299	small
I-Characteristic	1300	1303	ONH
I-Characteristic	1304	1308	size
O	1309	1311	in
B-Disease	1312	1315	DOA
O	1315	1316	,
O	1317	1325	strongly
O	1326	1333	suggest
O	1334	1338	that
O	1339	1347	patients
O	1348	1352	with
O	1353	1357	this
O	1358	1365	disease
O	1366	1369	are
B-Symptom	1370	1374	born
I-Symptom	1375	1379	with
I-Symptom	1380	1385	fewer
I-Symptom	1386	1391	optic
I-Symptom	1392	1397	nerve
I-Symptom	1398	1403	axons
O	1404	1407	and
O	1408	1415	support
O	1416	1419	the
O	1420	1430	hypothesis
O	1431	1435	that
O	1436	1446	subsequent
B-Symptom	1447	1453	visual
I-Symptom	1454	1458	loss
O	1459	1466	depends
O	1467	1469	on
O	1470	1477	further
B-Symptom	1478	1481	age
I-Symptom	1481	1482	-
I-Symptom	1482	1489	related
I-Symptom	1490	1494	loss
I-Symptom	1495	1497	of
I-Symptom	1498	1504	fibers
O	1504	1505	,
O	1506	1511	which
O	1512	1516	also
O	1517	1523	occurs
O	1524	1526	in
O	1527	1535	controls
O	1535	1536	.

O	1537	1540	The
O	1541	1547	author
O	1547	1548	(
O	1548	1549	s
O	1549	1550	)
O	1551	1555	have
O	1556	1558	no
O	1559	1570	proprietary
O	1571	1573	or
O	1574	1584	commercial
O	1585	1593	interest
O	1594	1596	in
O	1597	1600	any
O	1601	1610	materials
O	1611	1620	discussed
O	1621	1623	in
O	1624	1628	this
O	1629	1636	article
O	1636	1637	.
